Baohui Han

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer

Liang Zheng, Fang Hu, Lin Huang et al. · Journal for ImmunoTherapy of Cancer · 2024 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial

Jia Zhong, Kailun Fei, Lin Wu et al. · Signal Transduction and Targeted Therapy · 2024 · 15 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study

Wei Nie, Jun Lü, Jie Qian et al. · BMC Medicine · 2024 · 12 citations · Full text

Medicine, Oncology, Cancer Immunology +14

LBA4 Randomized phase III study of first-line selpercatinib versus chemotherapy and pembrolizumab in RET fusion-positive NSCLC

H.H.F. Loong, Keiko Goto, Benjamin Solomon et al. · Annals of Oncology · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +9

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy

Baohui Han, Jianlin Xu, Haitang Yang et al. · OncoTargets and Therapy · 2016 · 10 citations · Full text

Medicine, Oncology, Surgery +9